Etrolizumab (ITGA4_ITGB7) - Research Grade Biosimilar
Product Specifications
Background
Etrolizumab has been used in trials studying the treatment of Crohn Disease and Ulcerative Colitis.
Immunogen
Humanized / ITGA4_ITGB7 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
Anti-Beta7, PRO145223, RG7413, rhuMAb Beta7
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680226-500 1x 500 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880146-100 1x 100 µL
CD10 (CB-CALLA), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942460-500 1x 500 µL
Cyclin E (G1/S-Phase Cyclin) (CCNE1/2460), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740802-100 1x 100 µL
CD35 / CR1 (CR1/802), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041370-100 1x 100 µL
Adiponectin (Marker of Obesity) (ADPN/1370), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details